Top Page
Papyrus Australia Ltd
(Sydney:PPY)
Papyrus Australia Ltd (PPY) vs. iShares MSCI Australia ETF (EWA)
Papyrus Australia Ltd Business Overview & Revenue Model
Papyrus Australia Ltd Financial Statement Overview
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 672.96K | 0.00 | 0.00 | 257.03K |
| Gross Profit | -1.28K | -1.85K | 672.96K | 96.28K | -212.00 | 164.31K |
| EBITDA | -1.98M | -2.17M | -788.00K | -1.14M | -929.00K | -517.00K |
| Net Income | -2.60M | -2.80M | -644.00K | -1.50M | -1.18M | -90.78K |
Balance Sheet | ||||||
| Total Assets | 835.47K | 1.00M | 2.72M | 2.68M | 3.48M | 3.82M |
| Cash, Cash Equivalents and Short-Term Investments | 474.21K | 305.33K | 366.97K | 425.00K | 1.38M | 2.07M |
| Total Debt | 350.78K | 390.43K | 417.01K | 0.00 | 0.00 | 150.22K |
| Total Liabilities | 863.19K | 666.83K | 584.89K | 201.79K | 203.99K | 121.92K |
| Stockholders Equity | -27.72K | 337.71K | 2.14M | 2.48M | 3.27M | 3.70M |
Cash Flow | ||||||
| Free Cash Flow | -739.95K | -543.12K | -606.38K | -1.24M | -753.93K | -498.38K |
| Operating Cash Flow | -467.42K | -430.85K | -603.11K | -1.24M | -750.76K | -498.38K |
| Investing Cash Flow | -262.49K | -112.27K | -51.81K | -413.74K | -579.61K | -1.06M |
| Financing Cash Flow | 925.59K | 481.28K | 596.89K | 700.00K | 635.00K | 3.60M |
Papyrus Australia Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
53 Neutral | AU$137.52M | 34.52 | -13.37% | 2.84% | -2.31% | -279.94% | |
46 Neutral | AU$10.25M | -7.04 | -9.51% | ― | ― | -17.39% | |
42 Neutral | AU$7.24M | -2.08 | -48.72% | ― | ― | ― | |
42 Neutral | AU$9.59M | -1.73 | -56.10% | ― | ― | 44.90% | |
42 Neutral | AU$16.16M | -0.83 | -815.67% | ― | ― | 18.79% | |
41 Neutral | AU$5.55M | -2.44 | -231.57% | ― | ― | -284.62% |
Papyrus Australia Ltd Corporate Events
Papyrus Australia reported steady operational and commercial progress for the December 2025 quarter, highlighted by the near-completion of its Adelaide Rapid Prototyping and R&D facility, which will soon enable production of fibre-based moulded products, prototype validation and technology demonstrations for industry partners. The company also executed a significant supply contract with TBS Mining Solutions for exclusive global production of biodegradable Collar Keeper products, providing an estimated $4.2 million in revenue over 3.5 years from late FY26, while bolstering its financial position through option exercises, investor loans and an R&D tax refund, and removing legal overhang as proceedings brought against it were discontinued, collectively clarifying its pathway to initial revenues and commercialisation.
The most recent analyst rating on (AU:PPY) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Papyrus Australia Ltd stock, see the AU:PPY Stock Forecast page.
Papyrus Australia Ltd has reported the lapse of 4,545,454 listed options (ASX code PPYAI) that were due to expire on various dates at various exercise prices. The options ceased on 23 January 2026 because the conditions attached to these securities were not, or could no longer be, satisfied, resulting in a reduction of the company’s potential future dilutive securities and clarifying its issued capital structure for investors.
The most recent analyst rating on (AU:PPY) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Papyrus Australia Ltd stock, see the AU:PPY Stock Forecast page.
Papyrus Australia has taken a major step toward commercialisation by finalising a supply contract with TBS Mining Solutions, a subsidiary of Aquirian Limited, under which Papyrus will be the exclusive global producer of a fibre-based biodegradable Collar Keeper product for the mining sector. The agreement, expected to generate about $4.2 million in revenue over an initial 3.5-year term with an option for extension and product supply slated to start in the fourth quarter of FY26, validates the company’s technology and provides a clear revenue pathway while supporting the establishment of production-scale operations and further customer engagement. Complementing this, Papyrus reported strong progress in bringing its Adelaide Rapid Prototyping and R&D Facility close to full operational capability to support prototype development and industry partner engagement, confirmed that all resolutions at its 2025 AGM were carried, noted the discontinuance of legal proceedings brought against it earlier in the year, and disclosed receipt of a net $90,000 benefit from a research and development tax incentive after loan repayments and costs.
Papyrus Australia Ltd reported a positive operating cash flow of A$377,000 for November 2025 and A$187,000 for the financial year to date, driven largely by A$506,000 in government grants during the month and A$701,000 over five months, which more than offset staff, administration and finance costs. The company recorded A$136,000 in capital expenditure on property, plant and equipment, while net financing cash flow was slightly negative at A$368,000 for the month due to loan repayments exceeding proceeds from equity issuance and option exercises, resulting in a net increase in cash and cash equivalents of A$338,000 for November and A$303,000 year to date, underscoring the importance of grants and careful capital management to sustain its operations and investment program.
Papyrus Australia Ltd has issued 3.5 million fully paid ordinary shares at $0.01 per share to a service provider as non-cash consideration for services rendered, following prior shareholder approval at the company’s 2025 Annual General Meeting. The company advised that the shares were issued without a disclosure document under the relevant Corporations Act provisions, confirmed its ongoing compliance with financial reporting and continuous disclosure obligations, and stated there is no excluded information that investors would reasonably expect in a prospectus-style document, signalling that the issuance is a routine, compliant capital management step with limited immediate impact on existing shareholders.
Papyrus Australia Ltd has notified the market of the issue of 3.5 million unquoted options, exercisable at A$0.03 and expiring on 23 December 2027. The new options, which form part of previously announced transactions and are not intended to be quoted on the ASX, expand the company’s pool of equity-based instruments and may influence future capital structure and dilution for existing shareholders.
Papyrus Australia Ltd has applied to the ASX for quotation of 3.5 million new ordinary fully paid shares, to be issued on 23 December 2025 under its existing Appendix 3B arrangements. The additional quotation will expand the company’s listed share base, potentially affecting liquidity and ownership structure for existing and prospective shareholders.
Papyrus Australia Ltd has disclosed a change in the interests of director Arthur Stavrou, whose holdings are held indirectly through Emilart Holdings Pty Ltd, where he serves as director and shareholder. Stavrou has been issued 6 million unlisted options in lieu of directors’ fees, following shareholder approval at the company’s 2025 annual general meeting, lifting his indirect interests to 800,000 ordinary shares and options over 6 million shares at exercise prices of $0.01 and $0.02, expiring in 2027; the non‑cash remuneration structure underscores Papyrus’s use of equity-based compensation to align director incentives with shareholder outcomes while conserving cash.
Papyrus Australia Ltd, listed on the ASX under the code PPY, has notified the market of the issue of new unquoted options as part of previously announced transactions. These securities are not intended to be quoted on the ASX. The company has issued 2 million options exercisable at A$0.01 expiring on 19 March 2027 and 4 million options exercisable at A$0.02 expiring on 19 December 2027, potentially expanding its future capital base and providing additional incentives or funding flexibility for stakeholders.
Papyrus Australia Ltd has advised the market that 6,000,000 PPYAI options, which were subject to various exercise prices and expiry dates, have lapsed because the conditions attached to these options were not satisfied or have become incapable of being satisfied as of 18 December 2025. The cessation of these conditional rights reduces the company’s pool of outstanding options, simplifying its capital structure and potentially limiting future dilution for existing shareholders, though it does not involve any immediate change in the number of ordinary shares on issue or raise new capital for the business.
Papyrus Australia director Al Jawhari, who holds his interest in the company through several investment entities, has converted 10 million unlisted options into ordinary shares at an exercise price of $0.01 per share, representing a cash outlay of $100,000, while a further 6 million options have lapsed. Following the transaction, Jawhari’s indirect holdings have risen to 19 million ordinary shares in one vehicle, alongside unchanged stakes of 25 million and 814,374 shares in two other entities, consolidating his equity position and potentially signalling confidence in the company’s prospects while also simplifying its capital structure by reducing outstanding options.
Papyrus Australia Ltd has applied to the ASX for quotation of 10 million new fully paid ordinary shares under its ticker PPY, with an issue date of 18 December 2025. The additional securities expand the company’s quoted share capital, potentially enhancing liquidity in its stock and providing further capacity for capital management, though the announcement does not disclose specific use of proceeds or strategic rationale for the issuance.
Papyrus Australia Ltd’s latest financial report indicates a net cash decrease from operating activities, with expenditures in research, development, and corporate costs outweighing customer receipts. Despite this, the company secured additional funds through equity securities, resulting in a positive net cash flow for the period, potentially strengthening its financial position and supporting ongoing operations.
Papyrus Australia Limited announced the successful outcomes of its 2025 Annual General Meeting, where all resolutions were passed by a significant majority, reflecting strong shareholder support. The resolutions included the adoption of the Remuneration Report, re-election of board members, and approval of share and option issues, indicating a strategic move to enhance the company’s financial and operational capabilities, potentially strengthening its market position and stakeholder confidence.
Papyrus Australia Ltd has successfully finalized a contract with TBS Mining Solutions to manufacture and supply Biodegradable Collar Keeper Products, marking a significant milestone in the company’s transition from research to commercial operations. This contract, valued at approximately $4.2 million over 3.5 years, grants Papyrus exclusive global production rights and aligns with sustainable mining practices by eliminating plastic waste. Additionally, the company’s Adelaide Rapid Prototyping and R&D Facility has achieved key operational milestones, positioning it as a central hub for technology and product development as Papyrus prepares for commercial scale operations.
Papyrus Australia Ltd has transitioned from research and development to commercialization, marked by significant achievements such as the establishment of a Rapid Prototyping and R&D Facility and the execution of a contract with TBS Mining Solutions for biodegradable products. The company has also made strides in financial and governance restructuring, securing funding and resolving legal issues, which positions it for future growth and revenue-generating operations.
Aquirian Limited’s subsidiary, TBS Mining Solutions, has signed a contract with Papyrus Australia Limited for the production of biodegradable Collar Keeper® products. This contract, valued at approximately $4.2 million over three years, aims to enhance mining efficiency and sustainability by reducing plastic waste and improving safety. The product aligns with Aquirian’s Bootless Bench® vision, offering a greener alternative for blasthole stabilisation and setting a new standard for responsible mining practices.
Papyrus Australia Limited has signed a contract with TBS Mining Solutions Pty Ltd to manufacture and supply biodegradable Collar Keeper® products, marking a significant shift from research and development to commercial operations. This agreement, valued at approximately $4.2 million over an initial term of 3.5 years, positions Papyrus as the exclusive global producer of these eco-friendly products, which are designed to reduce plastic waste in the mining industry and support sustainable practices.
Papyrus Australia Ltd announced the discontinuance of a legal application filed against it by Perfection Australia Group Pty Ltd and Union Pacific Equities Pty Ltd in the Supreme Court of New South Wales. The parties have agreed to discontinue the proceedings, with Papyrus Australia Ltd agreeing to reimburse a portion of the legal costs incurred by the other parties, though the amount is confidential and not material. This resolution may positively impact Papyrus Australia’s operational focus and stakeholder relations by removing potential legal distractions.
Papyrus Australia Ltd announced the cessation of 10 million securities due to the lapse of conditional rights, as the conditions for these securities were not met. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s operational progress and strategic execution.